Trillium Asset Management LLC purchased a new stake in shares of LHC Group, Inc. (NASDAQ:LHCG) during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 21,128 shares of the health services provider’s stock, valued at approximately $1,301,000. Trillium Asset Management LLC owned approximately 0.12% of LHC Group at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the business. Systematic Financial Management LP increased its stake in LHC Group by 6.1% during the 1st quarter. Systematic Financial Management LP now owns 27,316 shares of the health services provider’s stock valued at $1,682,000 after purchasing an additional 1,570 shares in the last quarter. Envestnet Asset Management Inc. purchased a new stake in shares of LHC Group in the 1st quarter valued at $134,000. Thrivent Financial for Lutherans boosted its holdings in shares of LHC Group by 80.8% in the 1st quarter. Thrivent Financial for Lutherans now owns 18,313 shares of the health services provider’s stock valued at $1,127,000 after acquiring an additional 8,183 shares during the last quarter. Engineers Gate Manager LP purchased a new stake in shares of LHC Group in the 1st quarter valued at $915,000. Finally, Hood River Capital Management LLC boosted its holdings in shares of LHC Group by 2.0% in the 1st quarter. Hood River Capital Management LLC now owns 98,711 shares of the health services provider’s stock valued at $6,077,000 after acquiring an additional 1,922 shares during the last quarter. Institutional investors and hedge funds own 92.50% of the company’s stock.

In related news, COO Donald Dwayne Stelly sold 14,216 shares of the stock in a transaction on Tuesday, March 13th. The shares were sold at an average price of $64.00, for a total transaction of $909,824.00. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Joshua L. Proffitt sold 10,556 shares of the stock in a transaction on Thursday, May 17th. The stock was sold at an average price of $75.20, for a total transaction of $793,811.20. The disclosure for this sale can be found here. Insiders have sold 27,772 shares of company stock worth $1,920,685 over the last three months. 6.80% of the stock is currently owned by insiders.

Several analysts have recently commented on the stock. William Blair reaffirmed a “buy” rating on shares of LHC Group in a report on Sunday, May 6th. BidaskClub downgraded shares of LHC Group from a “sell” rating to a “strong sell” rating in a report on Wednesday, March 7th. Jefferies Group reaffirmed a “buy” rating and issued a $84.00 price objective on shares of LHC Group in a report on Wednesday, April 4th. Zacks Investment Research raised shares of LHC Group from a “hold” rating to a “strong-buy” rating and set a $70.00 price objective on the stock in a report on Tuesday, March 6th. Finally, Stephens set a $74.00 price objective on shares of LHC Group and gave the company a “buy” rating in a report on Friday, March 2nd. Two equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $76.80.

Shares of LHC Group opened at $73.34 on Wednesday, according to MarketBeat Ratings. LHC Group, Inc. has a 1 year low of $56.76 and a 1 year high of $76.91. The firm has a market cap of $1.36 billion, a P/E ratio of 30.31, a PEG ratio of 1.18 and a beta of 0.67. The company has a current ratio of 1.65, a quick ratio of 1.65 and a debt-to-equity ratio of 0.24.

LHC Group (NASDAQ:LHCG) last announced its quarterly earnings results on Wednesday, May 2nd. The health services provider reported $0.63 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.60 by $0.03. LHC Group had a net margin of 4.07% and a return on equity of 9.29%. The firm had revenue of $291.10 million for the quarter, compared to the consensus estimate of $295.21 million. During the same period in the prior year, the firm posted $0.53 earnings per share. The firm’s quarterly revenue was up 19.2% compared to the same quarter last year. research analysts anticipate that LHC Group, Inc. will post 3.5 EPS for the current year.

LHC Group Profile

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.